AprèsFlex

AprèsFlex is a patented, bioavailability-enhanced extract of Boswellia serrata gum resin standardized to 20% 3-O-acetyl-11-keto-beta-boswellic acid (AKBA), developed to provide rapid and sustained support for joint comfort and mobility[3][2][1][5][7]. The mechanism of action is centered on the inhibition of the enzyme 5-lipoxygenase (5-LOX), which plays a key role in the production of pro-inflammatory leukotrienes such as leukotriene B4[5][6][10][15]. AprèsFlex also inhibits matrix metalloproteinase-3 (MMP-3), which protects collagen in connective tissues[8]. Clinical studies demonstrate efficacy in reducing pain and improving physical function in osteoarthritis within five days of use, with a low daily dose (100 mg) and high safety profile[1][3]. It is used as a standalone ingredient in dietary supplements for joint health, frequently powering consumer brands for rapid, drug-free joint support[1][13].

Brand names

AprèsFlex

Other names

Aflapin